The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...
President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with drugmakers, rather than legislation. (Andrew Harnik / Getty Images) As ...
On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...
NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results